NCT06627556View on ClinicalTrials.gov

A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

February 27, 2025

Study Completion Date

February 27, 2025

Conditions
Ulcerative Colitis
Interventions
DRUG

H021

H021 oral tablet.

DRUG

H021 Placebo

H021 placebo oral tablet.

Trial Locations (1)

3004

RECRUITING

Nucleus Network Ply Ltd., Melbourne

All Listed Sponsors
lead

Jiangsu Carephar Pharmaceutical Co., Ltd.

INDUSTRY